HemCon, a struggling wound dressing device maker, is sold

A year after HemCon Medical Technologies filed for Chapter 11 reorganization following the loss of a patent fight, the Oregon maker of gels and dressings to control bleeding has been sold. TriStar Wellness Solutions in Connecticut disclosed that it bought the company for $3 million in cash, and now HemCon becomes a TriStar subsidiary. TriStar bills itself as a health and wellness company that targets under-met consumer opportunities in the over-the-counter and professional marketplaces. HemCon CEO Barry Starkman, a Merck ($MRK) and Genentech veteran who came on board last year, will remain in charge but also become a TriStar senior vice president. Release

Suggested Articles

BD will begin working with Babson Diagnostics to help bring its lab-quality device for collecting blood from capillaries into retail pharmacies.

The former CEO of the molecular testing company Foundation Medicine, Troy Cox, has been named chairman of the Swiss big data firm Sophia Genetics.

Researchers at MIT used a machine-learning algorithm to uncover the potent antibiotic properties hiding within an old small-molecule candidate.